Comment on: The use of anakinra in the treatment of secondary hemophagocytic lymphohistiocytosis

Pediatr Blood Cancer. 2021 Apr;68(4):e28813. doi: 10.1002/pbc.28813. Epub 2020 Nov 16.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Humans
  • Interleukin 1 Receptor Antagonist Protein*
  • Lymphohistiocytosis, Hemophagocytic* / drug therapy
  • Multiple Organ Failure
  • Retrospective Studies

Substances

  • Interleukin 1 Receptor Antagonist Protein